Purine content and gout risk
Inosinic acid is a purine nucleotide. When digested, purines are metabolised to uric acid. In people with gout or hyperuricaemia, elevated uric acid crystallises in joints causing acute, painful attacks. Dietary purine load from food additives such as inosinate salts adds to the load from purine-rich foods (offal, shellfish, anchovies). The absolute purine contribution from E633 at typical additive doses is small compared with, say, a portion of sardines, but cumulative intake across highly processed snack foods matters for people managing uric acid levels.
Inosinic acid (IMP) is a purine nucleotide metabolised to uric acid via xanthine oxidase; elevated uric acid is the direct cause of gout and contributes to kidney stone formation.
2004ObservationalChoi HK et al., New England Journal of Medicine
Dietary intake of purines from all sources, including nucleotide additives, raises serum uric acid in dose-dependent fashion in controlled feeding studies.
2009ObservationalFaller AL & Fialho E, Journal of Nutrition
Umami synergy and appetite stimulation
Inosinate additives are almost never used alone: their commercial purpose is to amplify the effect of glutamate (MSG) at lower combined doses. Some researchers have proposed that powerful umami enhancement may increase palatability of processed foods and contribute to overconsumption, though direct evidence linking inosinate itself (rather than the broader highly-processed food pattern) to harm is absent. The appetite-stimulation question is live but currently unresolved.
The combination of IMP and glutamate produces synergistic umami intensity many times greater than either compound alone, confirmed in both psychophysical taste tests and receptor-binding studies.
2000RCTYamaguchi S & Ninomiya K, Journal of Nutrition
Systematic reviews of umami substances and appetite have found inconsistent results; no intervention study has isolated inosinate additives as a driver of excess energy intake.
2014ObservationalMasic U & Yeomans MR, Physiology and Behavior
Regulatory safety review
EFSA's Panel on Food Additives and Nutrient Sources (ANS Panel) reviewed the inosinate and guanylate group as part of its systematic re-evaluation of approved EU food additives. The panel concluded there was no safety concern at the levels used in food and set no numerical ADI, noting that inosinic acid is a normal constituent of the human body. The review flagged gout sufferers as a sensitive subgroup.
EFSA ANS Panel re-evaluated E630-E633 (inosinic acid and its salts) and found no safety concern for the general population at current use levels, while noting that people with gout or hyperuricaemia form a sensitive group who may wish to limit purine intake.
2016Regulatory reviewEFSA ANS Panel, EFSA Journal